RBM15 and breast cancer: Furthermore, high expression levels of RBM15, PHGDH, PSAT1, PSPH, and SHMT2 were correlated with a worse prognosis in BC patients (Fig. 8d, Supplementary Fig. 19a, 19b) and TNBC patients (Supplementary Fig. 19c,, d).